<DOC>
	<DOC>NCT00147966</DOC>
	<brief_summary>Using repeated arthroscopic biopsies of patients with rheumatoid arthritis, the researchers will assess changes in the immune response that occur as a result of treatment with rituximab.</brief_summary>
	<brief_title>Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)</brief_title>
	<detailed_description>Using repeated arthroscopic biopsies of patients with rheumatoid arthritis, the researchers will assess changes in the immune response that occur after treatment with rituximab.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Active rheumatoid arthritis Use of concomitant methotrexate Use of diseasemodifying antirheumatic drugs (DMARDs)/biologics other than methotrexate Serious medical conditions that would preclude the use of the treating agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>active disease despite concomitant methotrexate</keyword>
</DOC>